Table of Contents

1 Global Market Overview

• 1.1 Scope of Statistics
  • 1.1.1 Scope of Products
  • 1.1.2 Scope of Manufacturers
  • 1.1.3 Scope of Application
  • 1.1.4 Scope of Type
  • 1.1.5 Scope of Regions/Countries
• 1.2 Global Market Size

2 Regional Market

• 2.1 Regional Production
• 2.2 Regional Demand
• 2.3 Regional Trade

3 Key Manufacturers

• 3.1 Roche
  • 3.1.1 Company Information
  • 3.1.2 Product & Services
  • 3.1.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.1.4 Recent Development
• 3.2 Amgen
  • 3.2.1 Company Information
  • 3.2.2 Product & Services
  • 3.2.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.2.4 Recent Development
• 3.3 AbbVie
  • 3.3.1 Company Information
  • 3.3.2 Product & Services
  • 3.3.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.3.4 Recent Development
• 3.4 Sanofi-Aventis
  • 3.4.1 Company Information
  • 3.4.2 Product & Services
  • 3.4.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.4.4 Recent Development
• 3.5 Johnson & Johnson
  • 3.5.1 Company Information
  • 3.5.2 Product & Services
  • 3.5.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.5.4 Recent Development
• 3.6 Pfizer
  • 3.6.1 Company Information
  • 3.6.2 Product & Services
  • 3.6.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.6.4 Recent Development
• 3.7 Novo Nordisk
  • 3.7.1 Company Information
  • 3.7.2 Product & Services
  • 3.7.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.7.4 Recent Development
• 3.8 Eli Lilly
  • 3.8.1 Company Information
  • 3.8.2 Product & Services
  • 3.8.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.8.4 Recent Development
• 3.9 Novartis
  • 3.9.1 Company Information
  • 3.9.2 Product & Services
  • 3.9.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.9.4 Recent Development
• 3.10 Merck
  • 3.10.1 Company Information
  • 3.10.2 Product & Services
  • 3.10.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.10.4 Recent Development
• 3.11 3sbio
  • 3.11.1 Company Information
  • 3.11.2 Product & Services
  • 3.11.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.11.4 Recent Development
• 3.12 Changchun High Tech
  • 3.12.1 Company Information
  • 3.12.2 Product & Services
  • 3.12.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.12.4 Recent Development
• 3.13 CP Guojian
  • 3.13.1 Company Information
  • 3.13.2 Product & Services
  • 3.13.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.13.4 Recent Development
• 3.14 Biotech
  • 3.14.1 Company Information
  • 3.14.2 Product & Services
  • 3.14.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.14.4 Recent Development
• 3.15 Gelgen
  • 3.15.1 Company Information
  • 3.15.2 Product & Services
  • 3.15.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.15.4 Recent Development
• 3.16 Innovent
  • 3.16.1 Company Information
  • 3.16.2 Product & Services
  • 3.16.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.16.4 Recent Development
• 3.17 Dong Bao
  • 3.17.1 Company Information
  • 3.17.2 Product & Services
  • 3.17.3 Business Data (Sales Revenue, Cost and Margin)
  • 3.17.4 Recent Development
• 3.18 Ganlee
  • 3.18.1 Company Information
  • 3.18.2 Product & Services
  • 3.18.3 Business Data (Sales Revenue, Cost and Margin)
• 3.19 United Laboratories
  • 3.19.1 Company Information
  • 3.19.2 Product & Services
  • 3.19.3 Business Data (Sales Revenue, Cost and Margin)

4 Major Application

• 4.1 Tumor
  • 4.1.1 Overview
  • 4.1.2 Tumor Market Size and Forecast
• 4.2 Diabetes
  • 4.2.1 Overview
  • 4.2.2 Diabetes Market Size and Forecast
• 4.3 Cardiovascular
  • 4.3.1 Overview
  • 4.3.2 Cardiovascular Market Size and Forecast
• 4.4 Hemophilia
  • 4.4.1 Overview
  • 4.4.2 Hemophilia Market Size and Forecast
• 4.5 Others
  • 4.5.1 Overview
  • 4.5.2 Others Market Size and Forecast

5 Market by Type

5.By Antibody

• 5.1 Antibody
  • 5.1.1 Overview
  • 5.1.2 Antibody Market Size and Forecast
• 5.2 Hormone
  • 5.2.1 Overview
  • 5.2.2 Hormone Market Size and Forecast
• 5.3 Growth Factors
  • 5.3.1 Overview
  • 5.3.2 Growth Factors Market Size and Forecast
• 5.4 Others
  • 5.4.1 Overview
  • 5.4.2 Others Market Size and Forecast

6 Conclusion

Summary
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
The global Biologics and Biosimilars market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
United Laboratories
Major applications as follows:
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
Major Type as follows:
Antibody
Hormone
Growth Factors
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa